Black Rock Inc. Milestone Pharmaceuticals Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,971,344 shares of MIST stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,971,344
Previous 4,971,344
-0.0%
Holding current value
$10.7 Million
Previous $8.9 Million
26.25%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MIST
# of Institutions
45Shares Held
28.7MCall Options Held
200Put Options Held
0-
Rtw Investments, LP New York, NY3.26MShares$7 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5.97 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$5.72 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$4.43 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$4.3 Million0.07% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $64.5M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...